Emergent BioSolutions
EBS
#6746
Rank
C$0.89 B
Marketcap
C$16.80
Share price
3.88%
Change (1 day)
26.62%
Change (1 year)

Emergent BioSolutions (EBS) - Total debt

Total debt on the balance sheet as of September 2025 : C$0.92 Billion

According to Emergent BioSolutions 's latest financial reports the company's total debt is C$0.92 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Emergent BioSolutions - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$0.95 B-16.52%
2023-12-31C$1.14 B-40.19%
2022-12-31C$1.90 B77.98%
2021-12-31C$1.07 B-3.91%
2020-12-31C$1.11 B5.27%
2019-12-31C$1.05 B-2.11%
2018-12-31C$1.08 B6277.26%
2017-12-31C$16.97 M-95.29%
2016-12-31C$0.36 B5.19%
2015-12-31C$0.34 B17.58%
2014-12-31C$0.29 B341.34%
2013-12-31C$65.99 M5.73%
2012-12-31C$62.42 M3.22%
2011-12-31C$60.47 M27.57%
2010-12-31C$47.4 M-31.44%
2009-12-31C$69.14 M-0.55%
2008-12-31C$69.52 M20.3%
2007-12-31C$57.79 M16.06%
2006-12-31C$49.79 M259.13%
2005-12-31C$13.86 M-10.28%
2004-12-31C$15.45 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Merck
MRK
C$57.69 B 6,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
C$0.81 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
C$33.27 B 3,498.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
C$3.65 M-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$84.84 B 9,076.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.80 B 2,474.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
C$0.53 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA